LGL Partners’s Pfizer PFE Stock Holding History

LGL Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,147	Closed	-$228K	–	97
2019 Q4	$228K	Hold	6,147	–	–	0.07%	97
2019 Q3	$210K	Buy	6,147 +53	+0.9%	+$1.93K	0.09%	101
2019 Q2	$250K	Hold	6,094	–	–	0.1%	96
2019 Q1	$246K	Buy	+6,094	New	+$244K	0.09%	95
2017 Q3	–	Sell	-6,493	Closed	-$207K	–	80
2017 Q2	$207K	Buy	+6,493	New	+$205K	0.11%	88

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

LGL Partners's PFE Position: Q1 2020 in Review

LGL Partners sold out of Pfizer (PFE) in Q1 2020, closing a stake of 6,147 shares — an estimated $228K sold.

LGL Partners first reported a position in PFE in Q2 2017 and held it in 5 quarters. The position peaked at $250K in Q2 2019. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

LGL Partners reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
LGL Partners sold 6,147 Pfizer shares in Q1 2020, an estimated $228K.
LGL Partners first reported a position in Pfizer in Q2 2017 and held it in 5 quarters.
LGL Partners's Pfizer position peaked at $250K in Q2 2019.
2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on LGL Partners's 13F filing for Q1 2020, filed 13 May 2020.